Skip to main content
Premium Trial:

Request an Annual Quote

Analytik Jena Launches French Subsidiary

NEW YORK (GenomeWeb News) – Analytik Jena today announced that its French subsidiary has begun operations.

The subsidiary, Analytik Jena France, will offer products from the parent firm's Life Science and Analytical Instrumentation divisions, Analytik Jena said. The company's portfolio includes thermal cyclers, electrophoresis and blotting instruments, and platforms for biomolecular interaction analysis.

Analytik Jena, which is headquartered in Jena, Germany, also said that seminars, in-house training, and application work will be offered through the French subsidiary.

"France is one of the important European markets for analytical instrumentation technology and life science products," Analytik Jena CEO Klaus Berka said in a statement. "The establishment of the subsidiary allows us direct access to this market. It is our strategic objective to expand Analytik Jena's global sales network further."

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.